We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 5 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 39 actions collected · 6 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 13. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2026. 03. 05. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 11. 08. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 08. 21. | Jefferies | — | Maintain | Hold → Hold | — | Jefferies: Hold |
| 2025. 08. 09. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2025. 08. 08. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 05. 09. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2025. 04. 09. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2024. 11. 04. | Jefferies | — | Downgrade | Buy → Hold | — | Jefferies: Buy → Hold |
| 2024. 10. 31. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2024. 10. 30. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2024. 10. 14. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2024. 09. 11. | Jefferies | — | Maintain | Buy → Buy | — | Jefferies: Buy |
| 2024. 08. 13. | Wolfe Research | — | Downgrade | Outperform → Peer Perform | — | Wolfe Research: Outperform → Peer Perform |
| 2024. 08. 10. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2024. 08. 09. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2024. 08. 08. | UBS | — | Maintain | Neutral → Neutral | — | UBS: Neutral |
| 2024. 05. 15. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2024. 04. 15. | Jefferies | — | Initiate coverage | — → Buy | — | Jefferies: Buy |
| 2024. 03. 02. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2024. 01. 03. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2023. 08. 11. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2023. 08. 11. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2023. 07. 24. | Wolfe Research | — | Initiate coverage | — → Outperform | — | Wolfe Research: Outperform |
| 2023. 05. 12. | Benchmark | — | Maintain | Buy → Buy | — | Benchmark: Buy |
| 2023. 03. 20. | Benchmark | — | Maintain | — → Buy | — | Benchmark: Buy |
| 2023. 01. 06. | Morgan Stanley | — | Maintain | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2022. 10. 12. | Morgan Stanley | — | Maintain | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2022. 09. 06. | CJS Securities | — | Initiate coverage | — → Market Outperform | — | CJS Securities: Market Outperform |
| 2022. 08. 17. | Morgan Stanley | — | Maintain | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2022. 04. 07. | Morgan Stanley | — | Maintain | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2022. 03. 18. | Morgan Stanley | — | Maintain | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2022. 03. 16. | Keybanc | — | Maintain | — → Overweight | — | Keybanc: Overweight |
| 2022. 01. 26. | Benchmark | — | Initiate coverage | — → Buy | — | Benchmark: Buy |
| 2021. 12. 09. | Stifel | — | Initiate coverage | — → Buy | — | Stifel: Buy |
| 2021. 12. 07. | UBS | — | Initiate coverage | — → Neutral | — | UBS: Neutral |
| 2021. 11. 10. | Keybanc | — | Maintain | — → Overweight | — | Keybanc: Overweight |
| 2021. 09. 30. | Morgan Stanley | — | Initiate coverage | — → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2021. 08. 20. | Keybanc | — | Initiate coverage | — → Overweight | — | Keybanc: Overweight |